Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
?

?

-0.680%
-0.2
-0.680%
-
 
03.06.26 / Stuttgart Stock Exchange WKN: A12FU4 / Symbol: ASTM / Name: Vericel / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Financial data and news for Vericel

sharewise wants to provide you with the best news and tools for Vericel, so we directly link to the best financial data sources.

News

Vericel Q1 Earnings Call Highlights
Vericel Q1 Earnings Call Highlights

Vericel (NASDAQ:VCEL) reported record first-quarter revenue and raised its full-year 2026 outlook, citing strong growth across its MACI cartilage

Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More: https://cdn.content.foolcdn.com/images/1umn9qeh/production/f5acfa2370b69ef05efd688fbbc9e56e546c0092-1401x1251.png?w=800&q=75&fit=max&auto=format
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More

Soleus Capital Management disclosed a significant buy of Vericel (NASDAQ:VCEL), adding 1,785,079 shares in the first quarter—an estimated $63.40 million trade based on quarterly average